Skip to content
10-K

Annual Report

cbdMD, Inc. YCBD

0001437749-25-038435

← back to feed
Filed
Dec 19, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Dec 16, 2025 9.42M sh
Shares Diluted FY 2025 · Sep 30, 2025 4.02M sh
Shares Diluted restated FY 2025 · Sep 30, 2024 539.07K sh
Capex FY 2025 · Sep 30, 2025 $184.17K
Capex FY 2025 · Sep 30, 2024 $190.02K
Operating Cash Flow FY 2025 · Sep 30, 2025 −$1.45M
Operating Cash Flow FY 2025 · Sep 30, 2024 −$352.79K
Cash And Equivalents FY 2025 · Sep 30, 2025 $2.26M
Cash And Equivalents FY 2025 · Sep 30, 2024 $2.45M
Stockholders Equity FY 2025 · Sep 30, 2025 $7.23M
Stockholders Equity FY 2025 · Sep 30, 2024 $1.96M
Stockholders Equity FY 2025 · Sep 30, 2023 $9.03M
Current Liabilities FY 2025 · Sep 30, 2025 $3.19M
Current Liabilities FY 2025 · Sep 30, 2024 $8.62M
Total Liabilities FY 2025 · Sep 30, 2025 $3.19M
Total Liabilities FY 2025 · Sep 30, 2024 $8.62M
Current Assets FY 2025 · Sep 30, 2025 $6.55M
Current Assets FY 2025 · Sep 30, 2024 $6.39M
Total Assets FY 2025 · Sep 30, 2025 $10.42M
Total Assets FY 2025 · Sep 30, 2024 $10.58M
Eps Diluted FY 2025 · Sep 30, 2025 −$1.09
Eps Diluted restated FY 2025 · Sep 30, 2024 −$14.29
Eps Basic FY 2025 · Sep 30, 2025 −$1.09
Eps Basic restated FY 2025 · Sep 30, 2024 −$14.29
Net Income FY 2025 · Sep 30, 2025 −$2.04M
Net Income FY 2025 · Sep 30, 2024 −$3.7M
Operating Income FY 2025 · Sep 30, 2025 −$2.16M
Operating Income FY 2025 · Sep 30, 2024 −$3.32M
Gross Profit FY 2025 · Sep 30, 2025 $11.97M
Gross Profit FY 2025 · Sep 30, 2024 $12M
Cost Of Revenue FY 2025 · Sep 30, 2025 $7.22M
Cost Of Revenue FY 2025 · Sep 30, 2024 $7.49M
Revenue FY 2025 · Sep 30, 2025 $19.19M
Revenue FY 2025 · Sep 30, 2024 $19.48M